Semi-Annual Changes to the NASDAQ Biotechnology Index
The following six securities will be added to the Index: Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), Synageva BioPharma Corp. (Nasdaq:GEVA), Merrimack Pharmaceuticals, Inc.(Nasdaq:MACK), Supernus Pharmaceuticals, Inc.(Nasdaq:SUPN), XOMA Corporation (Nasdaq:XOMA) and Zogenix, Inc. (Nasdaq:ZGNX).
The Index is designed to track the performance of a set of NASDAQ listed securities that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NASDAQ Biotechnology Index is re-ranked semi-annually in May and November. For more information about the NASDAQ Biotechnology Index, including detailed eligibility criteria, visit https://indexes.nasdaqomx.com/.
As a result of the re-ranking, the following two securities will be removed from the Index: Maxygen, Inc. (Nasdaq:MAXY) and Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX).
The NASDAQ Biotechnology Index is the basis for the iShares NASDAQ Biotechnology IndexSM Fund (Nasdaq:IBB), which seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index. In addition, options based on the NASDAQ Biotechnology Index and the iShares
About NASDAQ OMX Global Indexes
NASDAQ OMX Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the US All Market, Nordic, Green Economy, Sharia and Commodity Indexes. We continuously offer new opportunities for financial product sponsors across a wide-spectrum of investable products and for asset managers to measure risk and performance. NASDAQ OMX Global Indexes also provides custom index services and design solutions to selected financial organizations.
Daily index values, weightings and historical data for
For more information about NASDAQ OMX Global Indexes, visit https://indexes.nasdaqomx.com/.
About
The inventor of the electronic exchange,
The ETFs set forth above are not issued, endorsed, sold, or promoted by
NASDAQ OMX MAKES NO WARRANTIES AND BEARS NO LIABILITY WITH RESPECT TO THE ETFS.
The Industry Classification Benchmark ("ICB") is owned by
The iShares Funds are distributed by
IShares are not FDIC Insured.
Have No Bank Guarantee.
May Lose Value.
NDAQG
CONTACT: NASDAQ OMX Media Contact:Source:Wayne Lee +1.301.978.4875 Wayne.D.Lee@NASDAQOMX.Com NASDAQ OMX Issuer and Investor Contact:Lisa Chaney +1.301.978.8281 Lisa.Chaney@NASDAQOMX.Com
News Provided by Acquire Media